Human Genome Epidemiology Literature Finder
|
Records 1 - 8 (of 8 Records) |
| Query Trace: Hyperplasia and CYP2D6[original query] |
|---|
| The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2014 Jan 25 (1): 90-5. Dieudonné A-S, Lambrechts D, Smeets D, Belmans A, Wildiers H, Paridaens R, Hyonil C, Timmerman D, Christiaens M-R, Vergote I, Neven |
| Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacology 2014 94 (3-4): 183-9. Günald? Meral, Erkisi Melek, Af?ar Ci?dem Usul, Erçolak Vehbi, Paydas Semra, Kara I Oguz, Sahin Berksoy, Gulec Umran Kucukgoz, Secilmis A |
| Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans. European journal of clinical pharmacology 2018 Jun . Kim Kyoung-Ah, Park In-Bae, Park Ji-You |
| Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients. Frontiers in pharmacology 2021 12 12 661443. Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis |
| Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele. Archives of pharmacal research 2021 11 44 (11): 1037-1049. Cho Chang-Keun, Kang Pureum, Park Hye-Jung, Lee Yun Jeong, Bae Jung-Woo, Jang Choon-Gon, Lee Seok-Yo |
| Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin. Frontiers in pharmacology 2021 10 12 718281. Villapalos-García Gonzalo, Zubiaur Pablo, Navares-Gómez Marcos, Saiz-Rodríguez Miriam, Mejía-Abril Gina, Martín-Vílchez Samuel, Román Manuel, Ochoa Dolores, Abad-Santos Francis |
| Effects of CYP2D6 allelic variants on therapy with tamsulosin in patients with benign prostatic hyperplasia. Drug metabolism and personalized therapy 2023 9 . Skokhrukh P Abdullaev, Maksim N Shatokhin, Svetlana N Tuchkova, Sherzod P Abdullaev, Oleg V Teodorovich, Oleg B Loran, Dmitry A Sych |
| [Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study]. Urologiia (Moscow, Russia : 1999) 2023 12 (6): 5-13. P Abdullaev Sh, N Shatokhin M, N Tuchkova S, P Abdullaev Sh, V Teodorovich O, B Loran O, A Sychev |
- Page last reviewed:Feb 1, 2024
- Content source: